We are thrilled to announce AsymBio’s partnership with the 4th ADC Linker & Conjugation Summit, taking place July 28–30, 2026 in Boston, MA — the industry’s premier gathering focused on payload-linker , bioconjugation, and next-gen ADC. Our team will be on-site to showcase AsymBio’s award winning Conjugation Toolbox. Backed by in-house payload-linker and antibody CMC capabilities, we deliver integrated solutions covering early-stage development through clinical and commercial ADC manufacturing. Connect with our team to shape the future of ADC together. See you in Boston!

AsymBio is proud to be an Exhibition Partner at the 5th Targeted Radiopharmaceuticals Summit US in San Diego (July 21–23, 2026)! AsymBio is the leading CDMO solutions provider in RDC landscape — from process development to late-stage CMC. Visit us at our booth to learn how AsymBio supports partners across the radiopharmaceutical journey with integrated services that accelerate progress from molecule to market.

Webinar Invitation: Developing Efficient Downstream Purification for Bispecific Antibodies: Challenges and BreakthroughsAs bispecific antibodies continue to gain momentum across the biopharmaceutical landscape, efficient downstream purification is essential for achieving high product quality, manufacturing consistency, and scalable production.How can you overcome purification challenges such as aggregation, impurity removal, and process compatibility while improving downstream process efficiency?Join our upcoming webinar to explore practical strategies and enabling technologies for optimizing downstream purification of bispecific antibodies.Key Learning ObjectivesThe value and prospects of bispecific antibodiesChallenges in downstream process development and large scale productionCase study and strategies for Asymmetric bispecific antibodyStrategies of viral clearance studiesSpeakerPuya ZhaoSenior Director, Downstream Process Development, AsymBioClick to Register

At ASCO 2026, China-led ADC studies reached a new milestone, outnumbering U.S.-led studies for the first time.Is this a milestone - or the beginning of a broader shift in global oncology innovation?To explore this question, we are excited to launch the inaugural episode of China BioPioneers · International Edition—a new online panel series dedicated to fostering deeper dialogue between Chinese innovators and global industry leaders.Co-hosted by AsymBio, Asymchem Group, iSWT Community, Healthcare Executive, and Weijieyao, the series explores the ideas, innovations, and partnerships shaping the future of biopharma.Our first panel will bring together leaders from Merck, Orum Therapeutics, XYone Therapeutics, and leading Chinese biotechs MediLink Therapeutics and Lepu Biopharma to discuss:China–West Perspectives on Innovation, Globalization, and the Next Wave of ADC DevelopmentJuly 1, 2026 | 11:00 AM ETRegistration is now open: Click to Register

China’s radiopharmaceutical industry is entering a pivotal stage of growth, bringing unprecedented opportunities alongside new challenges across supply, manufacturing, clinical development, and commercialization.Join us on June 12 as experts from industry, academia, healthcare, and investment come together to share perspectives, exchange ideas, and explore how collaboration can help accelerate innovation and support the global advancement of China’s radiopharmaceutical sector.Date: June 12, 2026Panel Discussion: 1:00–6:00 PM (CST)Networking Dinner: 6:00–8:30 PM (CST)Muly Coffee & Bistro, Zhangjiang, Shanghai

Webinar Invitation | Key Considerations for an Effective CMC Development Strategy in ADC ProjectsAs ADCs continue to transform cancer treatment, the complexity of their development presents unique Chemistry, Manufacturing, and Controls (CMC) challenges. From conjugation strategy and analytical characterization to formulation development and regulatory planning, every CMC decision can have a significant impact on product quality, development timelines, and commercial success.How can teams build an effective CMC strategy that balances speed, quality, and scalability throughout ADC development? Join our upcoming webinar to explore key considerations and practical approaches for advancing ADC programs from early development through commercialization.Key Topics Include:Conjugation platform selection and its impact on DAR control and product homogeneity Analytical method development for complex ADC characterization Formulation and stability strategiesRegulatory and scalability considerationsSpeakerTiejun Li, PhDVice General Manager, Head of CMC and PM, AsymBioClick to Register

Webinar Invitation | Accelerating ADC Development from a Cell Culture Perspective: Efficient Process Optimization and Scale-upAs ADC pipelines continue to expand, the ability to achieve efficient antibody development and robust large-scale production has become a key determinant of overall timelines.How can you accelerate ADC programs through efficient upstream process development and seamless scale-up—without compromising quality or consistency?Join our upcoming webinar to explore how a strong cell culture strategy can drive speed, robustness, and scalability across ADC development.Key Topics Include:• Understand key considerations for efficient upstream cell culture process development• Gain insight into scaling processes from laboratory to production scale• Learn approaches for process characterization to ensure reproducibility and product qualitySpeakerZhenshou WangDirector, Cell Culture Process Development, AsymBioRegister Here: https://us06web.zoom.us/webinar/register/1617773388043/WN_4sf5i3juQQ-LqZg8M-glKA

We are thrilled to announce AsymBio as an official sponsor of the 5th ADC Analytical Development Summit taking place April 28–30, 2026 in Boston, MA! Visit the AsymBio booth to connect with our team and explore how we support your ADC projects.Tailored analytical development & characterization for novel drug conjugatesCollaborative problem‑solving for complex analytical CMC challenges This leading technical forum convenes 100+ senior analytical scientists and CMC leaders from top biopharma to solve critical challenges in ADC analytical development. We look forward to meeting you in Boston!

Let's Make Deals Happen.China's biotech innovation is booming—yet

Webinar Invitation | Decoding the Complexity of Novel ADC Constructs: Tackling Challenges in Analytical Method Development for CQA MeasurementAccurately characterizing critical quality attributes (CQAs) is becoming increasingly challenging as antibody-drug conjugates (ADCs) evolve toward more complex architectures such as bispecific and dual-payload ADCs.Join Dr. Zhao for practical insights into analytical method development for novel ADCs, with a focus on DAR determination, drug load distribution, free drug, and charge variant analysis. Key Topics Include:• Learn analytical strategies for novel ADC characterization• Explore DAR and drug load distribution analysis• Understand free drug and charge variant analysis• Apply fit-for-purpose analytical approaches for reliable CQA measurement Speaker:Qiang Peng, Ph.D.Director of ADC Conjugation Process Development, AsymBio Register Here: https://us06web.zoom.us/webinar/register/4017702578362/WN_fHGkjt2vRN6psuaojcbRwQ